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Abstract
It has been estimated that on average, every patient admitted to a hospital is subject to at
least one medication error per day (IOM, 2006). Errors may occur during various stages of the
Medication Use System; a system composed of various tasks performed from the point of
prescribing medication to the point in which a patient is monitored for adverse effects. Studies
have shown that a majority of the errors that occur during the Medication Use System have little
if any adverse effect on patients. However, there are classes of medication errors known as
Adverse Drug Events (ADE's) which can cause significant harm to a patient. ADE's are not
only dangerous but they have been estimated to cost the health care industry and the public in
excess of $3.5 billion dollars per year (1M, 2007).
While extensive, current literature that exists on preventable ADE's varies greatly in
regards how prevalent the issue is. The lack of a nationwide information system for identifying
and defining ADE's only exacerbates the problem. In addition, when significant errors do occur,
the repercussions for clinicians and hospitals are far from proportional.
Several studies suggest that over one quarter of all medication related injuries are
preventable (1M, 2007). Many industry observers have long touted computerized information
systems as the Holy Grail for reducing medication errors. While there is little question that
computerized systems can reduce ADE's, hospitals and clinicians frequently ignore other
solutions that can offer greater impact in improving the level of care that is being provided. The
health care industry has long been touted as fostering a culture that supports at risk behavior and
shuns the use of standardized processes. The lack of transparency into the health care industry
coupled with an unwillingness to embrace cultural change continues to be one of the largest
barriers in reducing the number of preventable ADE's.
This paper recommends 4 different solutions that will change the culture of the health
care industry, incent hospitals to focus on reducing preventable ADE's, improve the processes
already in place for providing patient care and provide clinicians with the most up to date health
care information available.
Thesis Supervisor: Christopher Caplice
Title: Executive Director, Master of Engineering in Logistics
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I Introduction
Every year, approximately 32 million people are admitted into U.S. hospitals for medical
treatment (1M, 2006). For many, medication is often part of their daily care regimen performed
while under the supervision of a clinician. Most people don't think twice about the possibility
that the medication being administered has the potential to cause them serious harm.
A recent survey of 173 people found 72% believe that a patient admitted to a hospital is
subject to zero medication administering errors per day (Appendix A). In contrast, a recent study
by the Institute of Medicine estimates that on average, every hospital patient is subject to at least
one medication error per day (1M, 2007).
Medication errors made within hospitals often go unnoticed or have little if any adverse
impact on a patient's health. Common medication errors of this type would include a clinician
who is instructed to administer two aspirin to a patient but instead administers three. In this
instance an error was clearly made, however the impact to the patient would typically be
negligible. In contrast, there are other types of medication errors known as preventable Adverse
Drug Events or preventable ADE's. Preventable ADE's differ from typical medication errors in
that they cause varying degrees of harm to a patient. An example of such an error would be a
nurse who administers penicillin to a patient known to be allergic to the drug. Typical allergic
reaction to a drug could vary from something as simple as a rash up to and including patient
death.
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It has been estimated that between 380,000 and 450,000 preventable ADE's occur each
year in the United States, while creating additional costs between $3 billion and $15 billion
dollars (Classen et al., 1997; Bates et al., 1995b; IOM, 2006). Additional studies have shown
that every year approximately 7,000 people are killed and approximately 1.5 million are injured
by medication errors (USA Today, 2006).
Today, the public has limited means of assessing the level of care being provided by their
hospital. There are agencies such as JCAHO (Joint Commission on Accreditation of Healthcare
Organizations) that provide hospital safety accreditation programs and reports from
organizations like U.S. News & World Report which have attempted to help the public in
determining the best hospitals in the country. However, many within the industry question the
means used in ranking and rating hospitals and attempting to utilize statistical data to quantify
the quality of care has long been a subject of much debate. What is clear is that medication error
or preventable ADE incident rates are not used in either the JCAHO or U.S. News & World
Report's accreditation and ranking studies. Even worse, the most widely respected accreditation
agency in the U.S., JCAHO, is jointly financed by the same hospitals that seek accreditation.
Studies have also shown that approximately 99% of all facilities that seek accreditation pass
which has caused many to question the validity of the program (Gual, 2005).
The objective of this thesis is to examine medication administering practices, health care
culture and the hospital industry to identify solutions that will have the greatest impact in
reducing the number of preventable ADE's.
The remainder of this thesis is organized as follows; Chapter 2 covers the current
literature that exists regarding medication errors and preventable ADE's. In addition, the
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difficulties in using previous research studies to determine preventable ADE incident rates are
discussed. Chapter 3 briefly discusses how the terms "medication errors" and "preventable
ADE's" have been used in past studies and how their various definitions have impact incident
rate reduction. The chapter also covers the methods used for detecting and reporting errors
within a hospital including the estimated ADE costs to the health care industry. Finally, I
examine the current reporting systems used by governmental and third party agencies to collect
medication error data from hospitals.
Chapter 4 covers the Medication Use System in detail by breaking down each of the 5
stages into their individual tasks. Each task in then covered in greater detail with an emphasis
put on those that have been shown to be highly associated with causing preventable ADE's.
Chapter 5 discusses the difficulty in attempting to use multiple studies in performing a
quantitative analysis of where the majority of errors occur during the Medication Use System.
The chapter touches on the possible reasons for the large discrepancy in the number of observed
ADE's between different studies and the criteria used in selecting "High Rates of Adverse Drug
Events in a Highly Computerized Hospital" as the main paper used in the analysis (Nebeker et al,
2005). Finally, the errors associated with preventable ADE's are categorized into the Medication
Use System in an attempt to determine what solutions would have the greatest impact in
reducing preventable ADE's.
Chapter 6 discusses the need for solutions to be implemented on a national level to have
the greatest chance of significantly reducing the number of preventable ADE's. In addition
solutions must first change the health care industries culture from one of accepting at risk
behavior to one of accountability. Various studies have shown that clinicians simply fail to use
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computerized systems that offer risk reduction (ISMP, 2007). Hospitals must then be incented to
include preventable ADE reduction into their daily operating plans. The processes that are
utilized in each hospital during the MUS must be streamlined and examined for compliance.
Finally, hospitals can then begin to use new computerized decision support systems which will
help reduce the variance in care that is received between the worst and best clinician.
Finally, while many of the solutions can have a significant impact on preventable ADE
reduction, there are financial and political repercussions in regards to their implementation.
Chapter 8 outlines future research that may further help to understand what solutions offer the
biggest benefit to the public while still providing a profitable environment for hospitals to
operate in.
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2 Research Methods
The research information and data gathered for this paper was accumulated from various
medication error studies completed during the past fifteen years, newspaper articles, medical
journals and textbooks. In addition, two hospitals were visited to observe general care practices
and to interview hospital personnel regarding how medication errors are generally addressed in a
hospital setting. Finally, an online survey was conducted in order to gauge public perceptions
and opinions regarding medication errors and preventable ADE's (Appendix A). Direct
observation of medication errors or preventable ADE's were not possible due the time allotted
for this thesis, the inability to provide the necessary technical expertise in identifying ADE's and
the lack of access to all stages within the Medication Use System.
All hospital visits were conducted at facilities within the United States. All hospitals and
personnel interviewed have requested to remain anonymous. Interviews consisted of discussions
regarding various stages of the Medication Use System and how medication errors and
preventable ADE's were perceived within each facility. In addition the interviews covered how
medication errors were tracked in each hospital and what processes or technologies had been
implemented in an effort to minimize the number of preventable ADE's.
The current literature regarding medication errors, while extensive, fails to clearly
indicate how pervasive preventable ADE's are within hospital settings. Broad and varying
medication error definitions used in the industry make it difficult to merge quantitative data
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between multiple studies. One study may define medication errors as "any inappropriate use of a
drug, regardless of whether that use resulted in harm" (Nebeker, 2004). In contrast, another may
use the definition "clinically significant" (Lesar, Briceland, & Stein, 1997). In addition, the
detection methods used in identifying errors significantly impact the number of incidents
observed (IOM, 2006). For example, several studies have noted that voluntarily reporting
methods substantially under represent the true number of medication errors and preventable
ADE's (IOM, 2007). In contrast, direct observation methods were the most effective in
detecting the highest number of errors (Flynn et al., 2002).
One of the major objectives of this thesis was to identify the various types of errors
within the Medication Use System that lead to preventable ADE's. However, a majority of the
journal articles and studies reviewed did not provide enough information to categorize errors into
the Medication Use System framework.
Finally, research and hospital reporting systems report error rates in varying ways; errors
per order/dose/opportunity, errors per 1,000 patient-days, and errors per 1,000 patient admissions
(IOM, 2006). For this reason there were various papers and studies that could not be combined
into the final results.
Because of the variances between how data is gathered, categorized and calculated, a
decision was made to utilize one study as the basis for observing preventable ADE incident rates
and segmenting contributing errors within the Medication Use System. After reviewing multiple
studies, Nebeker et al 2005 was used to provide the majority of the incident rate data used in this
thesis. The study examined ADE incident rates and errors across all stages of the Medication
Use System. In addition, the hospital examined was highly computerized, with a fully integrated
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CPOE (Computerized Physician Order Entry) system, bar-code administering system and an
electronic MAR (Medication Administration Record). It is important to note that the
computerized system installed in the hospital did not have decision support functionality such as
recommended drug selection, medication dosing or patient monitoring (Nebeker et al., 2005).
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3 Medication Errors & Adverse
Drug Events
Hospitals utilize various processes and guidelines when providing health care services to their
patients. When administering medications health care professionals strive to adhere to what are
called the "5 rights"; the right drug, in the right dose, by the right route, at the right time, to the
right patient (IOM, 2006). In general, any failure to adhere to these "five rights" constitutes a
medication error. However, medication errors can be classified in several different ways
according to various factors such as whether the error in question was foreseeable or how
significant the impact was on the patient.
It is important to clearly outline the various types of medication errors that exist within
the health care industry including the definitions that will be used within this research paper.
The lack of common definitions has always been a controversial subject and has led to vast
differences in how medical errors are studied and the incident rates at which they are detected.
Unfortunately, while the medical community has recently attempted to create common system
wide definitions for various types of medical errors, confusion is still commonplace in the
industry (1M, 2007). For the purposes of this research paper the table below lists the common
terms and definitions that will be used.
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Table 1 - Medical Error Definitions
Incident
Adverse drug event (ADE)
Preventable
Non-preventable
Medication error
Potential ADE
Definition
Injury due to any medication
Due to any error
Injury, but no error involved
Any error in any stage of the
Medication Use System
An incident with potential for
injury; all potential ADEs are
medication errors
Example
Drug rash
Coma due to overdose of
sedative
A allergic reaction due to a
medication given (Allergy not
known by patient or clinician)
Medication given at the
wrong time
An order was written for an
overdose of medication but
the mistake was intercepted
by the pharmacy
Source: Gandhi et al., 2000
Various studies have shown that the frequency of medication errors and preventable
ADE's vary greatly from study to study. While medication errors in general occur much more
frequently and the percentage of medication errors that lead to ADE's are minimal, this research
paper will only focus on preventable ADE's within the Medication Use System. It is important
to note that any type of medication error can be one of commission or omission. While it would
be beneficial to include both types of errors within this paper, there are significant gaps with data
in relation to medication errors created by acts of omission. Therefore, only preventable ADE's
created by errors of commission will be included in the study.
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The table below visually depicts the relationship between medication errors and the
various types of Adverse Drug Events.
Non-Preventable
Adverse Drug
Events
Medication Errors
Potential Adverse
Drug Events
Preventable Adverse Drug
Events
Source: IOM, 2007
Figure 1 - Medication Error Relationship
There are several different reasons on why this paper only focuses on preventable ADE's.
In general, it is believed that preventable ADE's occur due to factors such as various breakdowns
in the decision making process, failure to comply with general administering processes, lack of
knowledge about medications or drug reactions and poor communication between hospital staff.
These are all areas in which a health care IT (Information Technology) system with decisions
support functionality could potentially impact the rate of preventable ADE's. In addition,
beyond the significant costs that are associated with ADE's, serious cases of preventable errors
tend to be highly publicized. Events such as these can greatly impact the reputation of a hospital
and the overall public's trust in the health care system.
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3.1 Adverse Drug Event Costs
There have been several studies which have attempted to estimate the financial impact of a
preventable ADE. One study estimated the costs of preventable ADE's to be $8,750 per incident
in 2006 dollars (Bates et al., 1997). These estimates only accounted for additional costs inside
the hospital such as additional days spent receiving care or additional treatment and medication.
Using an estimate of 400,000 preventable ADE's per year the costs would be in excess of $3.5
billion in 2006 dollars (Bates et al., 1997). Many industry observers argue that the additional
costs created by ADE's are much higher when including a patients lost wages, additional
hospitalization and increased insurance premiums.
While large variances in estimates make it difficult to gain consensus regarding the true
financial impact of ADEs, most researchers and industry observers agree that ADE costs are
significant and severely impact the public and the health care industry.
3.2 Adverse Drug Event Detection
Studies have used various types of detection methods in an attempt to determine the number of
preventable ADE's within a hospital. The incident rates of ADE's detected in various studies are
directly correlated to the types of detection methods used (IOM, 2006).
The chart below lists the most common methods, the general yield rates and the typical
limitations experienced when utilizing each method.
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Table 2 - Error Rate Detection Method
Incident Method of identification Rates Detected Limitations
ADEs Voluntary reporting Low Low yield
Chart review Highest High cost / time
Computerized monitoring High Mostly number driven
Direct Observation High High cost
Source: (Bates & Gawande, 2000)
Historically, voluntary detection methods only capture approximately 5% of actual ADE
occurrences. There are multiple reasons that account for the large variances between this method
and other detection methods. First, hospitals have long feared that voluntary reporting will
increase the chances of facing litigation from patients that have experienced an ADE and
therefore only the most severe cases are reported (1M, 2006). In addition, hospitals also
believe that an increase in the reporting of preventable ADE's will lead to possible reprisal from
governmental health organizations such as JCAHO (1M, 2004).
Studies that use a chart review detection method tend to show the highest incident rates
of preventable ADE's when compared to other methods. The high rates observed can be
attributed to the fact that a patients MAR should contain all of the necessary information to
determine if a preventable ADE occurred. However, there are drawbacks to using chart review
as the main detection method. The process of reviewing charts requires a large amount of
training, a high level of medical expertise and is extremely time consuming. In addition, the
process is expensive to conduct and the very fact that humans are asked to use their judgment on
whether an ADE has occurred based on information in a chart means that there can be a great
deal of variation when using this method.
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Computerized monitoring allows users to quickly analyze records for preventable ADE's.
Users can create queries that contain constraints used to identify preventable ADE's (Bates &
Gawande, 2000). An example would be a system that flags any orders for Serum Vancomycin >
50mg/l; knowing that any level of this drug over this identified threshold is toxic and therefore
the system identifies that an error has occurred. The use of this type of automated detection
method is inexpensive when the costs of the IT systems themselves are not included. While this
type of detection method tends to be very accurate one should note that computerized detection
methods have difficulty in identifying ADE's that are expressed qualitatively.
3.3 Adverse Drug Event Reporting
There are various types of voluntary and mandatory reporting systems that exist to capture
medical error events. Some reporting systems are used solely by the health care industry while
others also have the ability to accept consumer inputted information. In many cases these
programs allow for the input of a wide range of medical errors beyond the category of ADE's.
Unfortunately many of these reporting programs share the same challenges; difficult to use
interfaces, low usage rates and poor data integrity.
3.3.1 Institutional Reporting Programs
Institutional reporting programs can include reporting systems that exist within the four walls of
a hospital and external reporting programs such as U.S. Pharmacopeia's MedMarx Program and
the Veterans Administration Patient Safety Reporting System.
While a reporting system inside of a hospital might be deemed as mandatory in relation
to reporting ADE's, external institutional programs are strictly voluntary. The health care
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industry has continually stated that any medical error reporting system must be free of punitive
consequences if the goal of such systems is to improve patient care (1M, 2006). However,
studies have shown that such reporting programs are very rarely used, especially when compared
to observed rates of ADE's within a hospital (10M, 2004). In addition there is little, if any
evidence beyond anecdotal references to these types of voluntary institutional reporting systems
improving the level of patient care (IOM, 2006). Many industry observers and politicians are
beginning to question the effectiveness of reporting systems created and governed by the health
care industry themselves (1M, 2006).
3.3.2 State Reporting Programs
According to the National Academy for State Health Policy (NASHP), an organization that
tracks state instituted reporting programs, 25 of the 50 states in the U.S. have instituted a
mandatory ADE reporting program in one form or another (NASHP, 2006). Each of the 25
states has different definitions of what types of ADE's must be reported and to what agencies
information must be forwarded to. However, many of the state implemented reporting programs
are difficult at best to understand. The table below shows the reporting definition for errors
within the state of South Dakota.
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Table 3 - South Dakota Mandatory Error Reporting Definition
Mandatory Error Reporting Definition (South Dakota)
44:04,:01:07. Reports. Each licensed facility, when requested by the department, shall submit
to the department the pertinent data necessary to comply with the requirements of SDCL
chapter 34-12 and this article.
Each nursing facility shall report to the department within 24 hours and any other
licensed facility shall report to the department within 48 hours of the event any death resulting
from other than natural causes originating on facility property such as accidents, abuse,
negligence, or suicide; any missing patient or resident; and any allegation of abuse or neglect of
any patient or resident by any person.
Each facility shall report the results of the investigation within five working days after the
event.
Each facility shall also report to the department as soon as possible any fire with
structural damage or where injury or death occurs; any partial or complete evacuation of the
facility resulting from natural disaster; or any loss of utilities, such as electricity, natural gas,
telephone, emergency generator, fire alarm, sprinklers, and other critical equipment necessary
for operation of the facility for more than 24 hours.
Each facility shall notify the department of any anticipated closure or discontinuation of
service at least 30 days in advance of the effective date.
Source: South Dakota Legislature (http://Iegis.state.sd.us/rules/DisplayRule.aspx?Rule=44:04:01:07)
In the case of South Dakota it appears that only ADE's that lead to the death of the
patient must be reported. Other serious types of drug errors such as those that lead to physical
impairment or a surgery on the wrong patient do not appear to rise to the level of being
forwarded to the state or other governmental agency.
While South Dakota is only one example, other states utilize just as confusing definitions
regarding what constitutes a reportable medical error or Adverse Drug Event.
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Similar to institutional reporting systems, evidence which supports that mandatory state
programs have improved patient care is largely anecdotal (Leape, 2002). Errors meeting the
requirements of mandatory reporting are not communicated to the proper agencies because of
fear of litigation (Leape, 2002). During an interview one hospital employee commented "In
today's litigious society we do not inform patients of medical errors if we don't have too".
3.3.3 Federal Reporting Programs
There are various reporting programs that have been instituted by federal agencies like the FDA
and the CDC. These federal reporting programs generally are composed of voluntary reporting
data from the health care industry and consumers in addition to mandatory reports from drug
manufactures (IOM, 2006). While many federal reporting systems gather data regarding
potential ADE events, their main goal is to address unknown effects of drug on drug interactions
or new information regarding recently released drugs. At this time there are no specific
mandatory ADE reporting programs in place at the federal level to monitor patient safety in the
health care industry.
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Medication Use System
The Medication Use System is a generally accepted framework within the health care industry
that is used to communicate the numerous steps involved in administering medication to patients.
Individual steps are segmented into 5 major groupings; prescribing, transcribing, dispensing,
administering and monitoring. It is important to note that this framework applies to a hospital
setting only. Different processes are used in other settings such as private doctor's offices,
outside pharmacies, ambulatory care and outpatient health care facilities. In addition, while the
framework shows the typical steps involved in administering medication it should only be used
as a guideline. No two hospitals operate in the same manner and actual processes will vary from
facility to facility.
The framework, used in conjunction with error rate observation data, helps to identify
where in the process the majority of errors occur which lead to preventable ADE's.
The figure below depicts the Medication Use System and various tasks which are related
to each category.
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Prescribing
Clinical decision
rnaking
Drug choice
Drug regimen
determination
Medical record
documentation
Order (written,
verbal, electronic)
Source: IOM 2007
Transcribing
Retrieve order
or retrieve from
Check if
correct
E-Prescribing
Dispensing
Data entry and
screening
Preparing mixing
compounding
Pharmaci double
check
Dispensing to unit
Administering
Drug
preparation for
administering
Nurse verifies
orders
Dru 9
administered
Documentation
in MAP*
Monitoring
Assess for
therapeutic effect
and adverse effect
Review laboratory
results if
necessary
i
Treat adverse
drug event if
occurring
Documentation in
MAP'
Figure 2 - Medication Use System
4.1 Prescribing Process
The prescribing stage of the Medication Use System involves several steps which ultimately lead
to a medication being prescribed for a patient. Generally a clinician will meet with a patient to
evaluate their current health state and to address the patient's particular ailment. In addition, the
clinician uses this time to discuss possible treatment plans, medications that address the
underlying ailment and finally should answer questions that the patient might have regarding the
treatment plan or the medication. A typical doctor's visit requires that the clinician weigh
multiple factors in determining the type of care to be provided. Clinicians must take into account
a patient's health history, potential drug side effects, interactions with over the counter
supplements, medication dosage in relation to desired effect and whether the formulary being
prescribed is covered by the patients insurance (Goodman & Gilman, 2001).
Studies have shown that most errors that occur within the prescribing process are due to a
lack of knowledge by the physician (Bates et al., 1995a). This lack of knowledge may include
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current information regarding treatments for diseases or the most up to date information
regarding drug on drug interactions. One of the major issues identified during the prescribing
process is the physician's poor handwriting and the use of abbreviations when manually filling
out prescriptions. The table below identifies some of the "Do Not Use" lists that have been
created by JCAHO.
Table 4 - Do Not Use Medication List
Do not use:
U (unit)
IU (International Unit)
Q.D., QD, q.d., qd (daily)
Q.O.D., QOD, q.o.d, qod
(every other day)
MS
MS04and MgSO4
Potential problem
Mistaken for "0" (zero), the
number "4" (four) or "cc"
Mistaken for IV (intravenous)
or the number 10 (ten)
Mistaken for each other
Period after the Q mistaken
for "I" and the "0" mistaken
for "I"
Can mean morphine sulfate or
magnesium sulfate
Confused for one another
Use Instead
Write "unit"
Write "International Unit"
Write
Write
"daily"
"every other day"
Write "morphine sulfate"
Write "magnesium sulfate"
Source: Adapted from www.ismp.org
Once a medication regimen has been established the clinician must then translate these
orders into a prescription. Prescription orders can be generated in several different ways
depending on the systems that are in place within a hospital. The process of creating the
prescription and sending the order to the pharmacy or the nurse is part of the transcribing
process.
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4.2 Transcribing Process
Hospitals may use varied methods and processes for communicating prescription orders to the
pharmacy or the nurse. Prescriptions may be communicated by carbon copies of original orders,
faxes, scanned copies, phone and electronic orders or complicated CPOE systems (IOM, 2006;
Manasse, Thompson, 2005). The size of a hospitals budget may also adversely impact the
transcribing process by limiting the ability to use solutions known to reduce errors.
Once a prescription has been created by a physician and communicated to the pharmacist
the prescriptions must then be filled. The orders that are sent to the pharmacy from the physician
typically contain the patients name, drug name, dosage, formulation, route, frequency, units,
flow rates, duration and reconstitution information (IOM, 2006;Manasse, Thompson, 2005). If
the pharmacist or the nurse has any questions regarding the order it is standard procedure that
they must directly contact the physician who wrote the prescription (Cohen, 2000; IOM 2006).
The majority of errors that occur during the transcribing process are related to the ability
of the pharmacist to interpret written prescriptions. Even prescriptions that are written clearly
can become illegible depending on the method of communication such as faxing. While poor
hand writing by a physician is identified as a major issue during the prescription stage, the use of
certain abbreviations and symbols can also create potential problems. The table below lists some
common forms of abbreviations and symbols that have been identified to cause errors.
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Table 5 - Error Prone Abbreviations and Symbols
Abbreviations Intended Meeting Misinterpretation Correction
At Mistaken as "2" Use "at"
& And Mistaken as "2" Use "and"'
cc Cubic centimeter Mistaken as "u" Use "ml"
(u nits)
And < Greater than and less Mistaken as opposite Use "greater than" or
than of intended; "less than"
mistakenly use
incorrect symbol;
10" mistaken as "40"
Source: Adapted from www.ismp.org
Misinterpreting a symbol or an abbreviation typically does not impact the actual drug that
is prescribed but can affect the dosage or the form (liquid, pill, IV). In addition, the wrong drug
can be filled due to the fact that many medications have similar names.
The table below lists several examples of medications that can easily be confused for
other drugs.
Table 6 - Confusing Drug Names
Drug Name Possibly Confused With
Accupril Aciphex
Altocor Advicor
Cedax Cidex
Cozaar Zocor
Femara Femhrt
Metadate CD Metadate ER
Source : Adapted from www.ismp.org
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Finally, pharmacists that do not have access to a computerized pharmacy drug database
and patient information lack the ability to perform an in depth medication reaction review. This
lack of information and knowledge about the patient's history and the medications they are
taking can also lead to preventable ADE's.
Once the physician's prescription has been reviewed and verified the medication must
then obtained and put into dose form for the patient. The tasks involved are known as the
dispensing process.
4.3 Dispensing Process
Studies have estimated that dispensing errors account for approximately 6% to 12% of all
medication errors (IOM, 2006). Following the review of a prescription by a pharmacist the order
must then be entered into a pharmacy database system. Pharmacy database systems are used to
screen for possible drug interactions, patient's history to allergies, dosage tolerance levels and
possible duplicate prescriptions. More complicated pharmacy database systems have the ability
to screen prescription orders against patients test results which have been shown to help reduce
potential ADE's (Manasse & Thompson, 2005; IOM, 2006).
Studies have shown that approximately 91% of hospitals and pharmacies have a
computerized pharmacy data base system. Of the hospitals and pharmacies that have these types
of database systems approximately 87% include data such as patient admission and discharge
records (Ringold et al., 1999). It is important to note that any changes made to a prescription
necessitates that the original physician be contacted. The physician must then determine if the
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changes are valid. The prescription should then be resubmitted and the entire verification
process proceeds as normal.
Once the order has been verified and entered into the database system it must then be
fulfilled by the pharmacist. This process can involve the counting or measuring of the
medication and in some instances the mixing of multiple compounds to create the final drug. In
addition, the pharmacist may be required to repackage the drug and label the contents. Within
the dispensing process these steps have been found to attribute to the greatest number of
medication errors within the pharmacy (Manasse & Thompson, 2005; IOM, 2006). It has been
shown that between 79% and 99% of hospital pharmacists repackage oral medications and 29%
repackage medications that can be injected (1M, 2007). Because of the potential risk involved
in labeling and repackaging medications in hospital settings a new federal regulation will go into
effect in 2007 that will require manufactures to provide medications to hospitals already in unit
dose form (FDA, 2004). Because these requirements are relatively new, there are no studies
which address the impact this new regulation has had on reducing medication errors or
preventable ADE's.
Studies have shown that a majority of the errors that occur during the dispensing process
are due to workload issues, distractions during the processing of the medication and a lack of a
computerized pharmacy database system or one with outdated or incorrect information (IOM,
2007).
Computerized drug database systems are a vital piece of the preparation and dispensing
process due to their ability to automatically detect potential ADE's that the pharmacist could
possibly miss. In addition, the rate at which new medications are released into the market has
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made it difficult for even the best pharmacists to remain educated regarding potential drug
reactions and side effects. A study also determined that dispensing errors are directly correlated
to the amount of interruptions and distractions a pharmacist faces during the dispensing process
(Flynn et al., 1999).
Once the prescription has been verified and repackaged into a single patient dosage the
medication must be made available to the nurse. It is important to note that both the pharmacist
and the nurse are involved in properly making the medication available and retrieving the
medication from storage.
In most hospitals medications are retrieved from ward based medication storage units.
These units could be as simple as shelving units within the ward and as complicated as
computerized automated dispensing cabinets (Appendix B) which can run reports, limit access to
certain personnel and complete other dispensing tasks. Decentralized automated dispensing
systems have been shown to help reduce errors during the dispensing process (Cohen, 2000). In
an automated dispensing unit scenario the pharmacist is responsible for inputting the correct
patient data into the system and making sure that the corresponding medication is available in
each bin. The nurse is then responsible for retrieving the medication from the automated
dispensing unit, verifying the medication and administering it to the correct patient.
4.4 Administering Process
The administering stage of the Medication Use System is the last step in which many preventable
ADE's can be detected prior to causing harm to a patient. In cases where medications are
administered by intravenous methods, ADE's can occur quite rapidly, with little if any time to
address errors (IOM, 2007).
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Once a drug is retrieved from a medical storage unit, medications should be kept separate
to avoid contamination with other prescriptions. Once retrieved, the medications should be
verified to make sure they are correct. Studies suggest that medications should be verified at
three distinct stages; when retrieved from the storage unit, at bedside with the patient and after
discarding (Cohen, 2000; Manias et al., 2005). Once the medication has been verified it is then
administered to the patient and the MAR is updated with all relevant information.
There are various reasons within the administering process why errors can occur. The
environment for nurses can be very demanding, with long work hours and inadequate staffing
conditions (Castle & Engberg, 2005). Nurses are very often subject to tasks that interfere with
providing high levels of patient care such as performing housekeeping tasks, delivering meals
and performing other non-job related functions (IOM, 2004; IOM, 2006). On average hospitals
incur a nurse turnover ratio of 21.3% per year (IOM, 2007). These high turnover ratios reduce
the pool of educated and experience nurses in hospital settings.
Nurses must also ensure that drug infusion or administering devices are working
correctly. Some devices are computerized and they must be programmed to ensure that the right
dosage is being administered in the right time frame based on the prescription (IOM, 2007).
The verification of the medication by the nurse is seen as one of the most important step
in the Medication Use System because studies have shown that nurses catch approximately 86%
of all medication errors prior to administering (Leape et al., 1995). For this reason, nurses are
also subject to many of the same issues that pharmacists experience. Medication administering
instructions are often difficult to read, completely illegible or incomplete. If nurses are not
diligent regarding drug verification procedures preventable ADE's can occur.
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Finally, the rate at which new technology systems and medicines are being introduced
make it difficult for clinicians to remain up to date best practice procedures.
4.5 Monitoring Process
Once a medication has been administered to a patient they must then be monitored. Monitoring
enables the clinician to determine the effectiveness of the medication and to determine if there
are any adverse reactions. The signs that accompany ADE's are often times difficult to diagnose
depending on the drug administered and where in the Medication Use System occurred. For
instance, the reaction in a patient to a drug that was administered in a toxic dose can be
completely different when compared to an allergic reaction from the same drug.
Monitoring of a patient can involve different steps of evaluation, observation and
surveillance (IOM, 2006). The monitoring process can differ greatly based upon multiple factors
such as a patient's age, weight or additional medical procedures performed. Hospitals may also
differ greatly in the frequency and length of time used in monitoring patients.
The process of monitoring a patient is seen as one of the most crucial steps in detecting or
preventing ADE's (IOM, 2006). In a hospital setting the act of monitoring a patient and
assessing drug impact is the primary responsibility of a nurse (IOM, 2007). Monitoring a patient
is done by visual observation, using monitoring devices and assessing lab results or tests
(Manasse & Thompson, 2005). During this time important vital signs are monitored such as
heart rate, blood pressure, patient pain and fluid levels (IOM, 2006). The use of a cardiac
monitor after the administering of a drug is an example of automated monitoring. If the monitor
detected an abnormal change in heart rate the nurse would be immediately notified of a possible
reaction to the drug and hence a possible ADE. It is important to note that may adverse reactions
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to medications cannot be monitored solely by automated means and that a large part of the
responsibility falls on the patient themselves to continually communicate any changes in their
level of health (dizziness, dry mouth, rash) (IOM,2006).
In hospitals with electronic MAR's, pharmacists can play a role in the monitoring
process. As MAR's are updated and additional prescriptions are ordered a pharmacist is better
able to provide input as to the care a patient is receiving (IOM, 2006). Finally, during the various
stages of the monitoring process patient information is recorded into the MAR in order to
determine the progress of the healthcare being provided and to help other health care givers
remain up to date regarding the patient's condition between shift transitions.
The majority of preventable ADE's that occur during the monitoring stage are due to
failure in following monitoring procedures or missing the signs of a preventable ADE due to a
lack of knowledge or education (IOM, 2004). In many cases patient's symptoms are either
identified too late or are perceived as not being serious enough to immediately act upon.
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5 Medication Error and Adverse
Drug Events Incident Rates
One of the major objectives of this thesis was to use data from multiple studies in calculating an
"average" preventable ADE incident rate per 1,000 hospital admissions. In addition, multiple
studies would be used to determine what stages of the Medication Use System produced the
majority of medication errors that lead to preventable ADE's.
After reviewing the research data from multiple papers it became obvious that the
qualitative and quantitative data variances between studies would make it impossible to merge
information. There were several reasons for the large variances; the definition of an ADE varied
dramatically from study to study, the methods used for error detection were varied, different
ratios were used when calculating error rates and many of the studies did not identify errors
using the Medication Use System.
An example of the dramatic differences in observed rates is shown below in Table 7.
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Table 7 - Preventable Incident Rates (Per 1,000 Admissions)
Study ADE's Per 1,000 Admissions Proportion of ADE's
Preventable
Classen et al., 1997 2.4 Approximately 50%
Senst et al., 2001 4.2 15%
Bates et al., 1995b 6.5 28%
Nebeker et al., 2005 52 27%
Source: IOM, 2007
Because of the significant variability observed in the studies in Table 7 and the difficulty in
attempting to merge the data, an attempt was made to identify a single study that met the
following criteria;
1. Electronic detection method utilized & chart review
2. Study completed within the past five years
3. Hospitals that utilized computer integrated systems (CPOE, MAR, etc)
4. Incident rates that could be segmented into the Medication Use System framework
The criteria listed above were selected for several reasons. First, detection methods using
electronic methods and manual chart review have been shown to more accurately identify
incidents when compared to other methods (IOM, 2006). Second, hospitals have made
significant strides over the past 5 years in reducing medical error rates with the use of
automation, improved processes and technology. A study that was recently conducted would
give a more accurate representation of what is occurring in the health care industry today.
Additionally, studying hospitals that have already implemented computer based systems such as
CPOE and electronic MAR's could provide further insight into their impact on reducing
preventable ADE's. Finally, studies where errors can be segmented into the Medication Use
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System stages will provide the necessary insight into what types of solutions may offer the
greatest impact in reducing preventable ADE's.
After reviewing in excess of 15 studies completed on medication errors within hospital
settings the Nebeker et al 2005 study met the majority of the criteria. The study reviewed a 110-
bed VA hospital that had integrated computerized medical systems which recorded all orders,
results, medications and notes. The CPOE system was activated to check for allergies, several
different types of drug-drug interactions and a small number of drug-disease interactions. At the
time of the study the systems did not offer decision support algorithms such as drug selection,
dosing or monitoring advice.
The hospital had a fully integrated bar coding system and had already implemented
systems well known for reducing ADE's, including patient safety coordinators, unit dosing and
clinical pharmacists that directly observe patients. The threshold for meeting an ADE was
defined as "injury resulting from the use of a drug". Finally, all electronic record reviews were
completed by at least two clinical pharmacists.
Of the 937 hospital admissions that were reviewed, 483 patients experienced an adverse
drug event. Of the 483 patients that suffered an ADE, 27% were due to medication errors and
therefore deemed to be preventable. In comparison to a landmark study completed by Bates et
al. 1995b, the number of observed detected preventable ADE's in the Nebeker study were
significantly higher.
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The figure below shows that large variance between three of the major studies that are
commonly referred to in the health care industry when addressing preventable ADE's.
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Figure 3 - Preventable ADE's Per 1,000 Admissions
The high number of detected ADE's in relation to other studies can be attributed to two
major factors. First, only recently have ADE incident rates been studied in highly computerized
hospitals. The study by Nebeker utilized electronic detection methods versus the manual chart
review and prompted reporting methods used in the Bates study. Second, the Nebeker study
used the broader WHO (World Health Organization) definition for what constituted and ADE in
contrast to the more restrictive definitions used in other studies.
The high rate of observed ADE's bring into question both the effectiveness of previous
studies in identifying ADE's and the impact that health care information technology systems
have in ADE reduction.
Many studies have estimated that approximately one quarter of ADE's can be prevented
with the use of IT solutions which can identify errors within the Medication Use System (Bates
et al., 1995a; Nebeker et al., 2005). According to one study, CPOE and other automated
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computer systems have been so successful in identifying ADE's that many have touted
automation as being essential to reducing the number of events (Bates, 2001). However, the high
rates of observed ADE's in the Nebeker study bring into question the effectiveness of such
systems.
Extrapolating for 1,000 admissions, approximately 181 errors contributed to the 135.4
preventable ADE's observed in the study (Nebeker et al., 2005). The chart below shows the
errors segmented into the 5 stages of the Medication Use System.
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Source: IOM, 2007
Figure 4 - Percentage of Errors by Stage
The observed rates of errors during the transcribing and dispensing stages, while low in
comparison to other studies, reflect how a well integrated CPOE system and medication
dispensing unit solution (Appendix B) can help reduce errors within the Medication Use System.
These types of solutions are especially effective because typically, clinicians cannot bypass these
systems and revert to older, more risky methods. For example, once a CPOE system is
implemented, written prescriptions are no longer accepted and therefore any risk associated with
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translating a doctors poor handwriting is removed from the process. Depending on the type of
medication error, an occurrence during the transcribing or dispensing phase is more likely to lead
to a preventable ADE when compared to the prescribing phase. This is due to the fact that there
is less of an opportunity for clinicians to identify an error the closer the occurrence is to the
administering stage.
In contrast to the transcribing and dispensing stages, rates of errors observed during the
prescribing, administering and monitoring stages are extremely high. These three stages rely
heavily on a clinician's training and expertise when providing patient care. For example, during
the prescribing stage, a physician must diagnose a patient's symptoms and correctly prescribe the
correct medication and dose required. An incorrect diagnosis or an error in regards to the dose
could lead to the administering of a drug which could cause an ADE. Another example would be
during the monitoring stage, a nurse who fails to start or complete adequate monitoring for
known common medication errors may miss signs of an appending ADE. The hospital involved
in this study, while having an extensive computerized system installed, did not support advanced
decision support functionality. Smart pumps (Appendix C) and computerized databases of up to
date drug interaction information could help clinicians during these stages. However, unlike
solutions which completely replace older processes, decision support systems are used as a
supplement to the care being provided by clinicians. Therefore, they are often perceived as
optional, severely reducing their effectiveness.
Reducing errors during these stages is difficult because only making decision support
systems available to clinicians are not an effective strategy. Solutions must be coupled with a
plan to induce a cultural change within the hospital that helps clinicians embrace the use of these
systems. In a safety brief given by the ISMP it was determined that the majority of nurses in a
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hospital bypassed the dose checking technology in all smart pumps (ISMP, 2007). There were
several reasons given for not using the technology; perceived view of low risk, difficulty in using
the technology and clinical emergencies.
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6 Recommendations
Unlike many industries, errors within hospital settings have significant consequences. Utilizing
technology solutions has often been a major way in which hospitals have tried to improve the
quality of their care. Solutions such as electronic MAR's and CPOE systems are extremely
beneficial because they are typically not viewed as barriers by clinicians in their daily work
routines and they are often difficult to bypass. On the other hand, the use of decision support
systems is often presented to clinicians as optional. As an example, the use of smart IV pumps
has been shown to significantly reduce the number of errors during the administering stage, yet
in one study over half of all nurses in a hospital failed to use the safe dose-checking technology
(ISMP, 2007). Hospitals must be strongly influenced to use solutions that improve patient care.
The health care industry has a culture that often supports at-risk behavior and technology
workarounds while shunning standardized processes (ISMP, 2007). When addressing the failure
of some hospitals to adopt standardized procedures when providing patient care, Dr Richard
Croteau, executive director of patient safety initiatives for the JCAHO, stated, "Health care puts
a high priority on individual autonomy, some of this goes against the traditional culture."
(Kowalczyk, 2007).
Reducing the number of preventable ADE's involves creating a culture of accountability
in the hospital industry, incenting facilities to reduce errors, improving processes already in place
and adopting technology that reduces the variance in the level of care received between the best
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and worst hospitals. The recommendations presented later in the chapter address all of these
areas.
6.1 Cultural Change
The first step in driving cultural change within the industry is to implement policies which
embrace accountability and provide the necessary information for educational and punitive
purposes. One way to achieve this is to implement a transparent, mandatory nationwide
reporting system which can account for all preventable ADE's in hospital settings. A mandatory
reporting system would provide the necessary data to identify what types and where the majority
of errors are occurring within the Medication Use System. This data could also be used to
improve clinician education by incorporating the information into future decision support
systems.
The recommended mandatory reporting program would require that all preventable
ADE's be input into an online error database run by a segment of the U.S. government. Failure
to input complete, accurate and timely data would result in punitive measures including fines and
possible closure of facilities. Preventable ADE's would be defined as "any medication error that
causes mental or physical injury, long or short term, and - or requires the use of additional
medical intervention".
6.1.1 Reporting Structure
The reporting system would be web based with the ability to integrate into computerized hospital
systems via XML and ODBC. Facilities that do not have integrated computerized systems
would have the ability to enter error data via a browser interface. The system would also allow
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for the entry of data by a patient where questions or concerns could be input requiring additional
follow up by the hospital.
The reporting system would collect the following data;
" Patient specific data
" Preventable ADE
" Hospital employees involved in the ADE
" Stage of Medication Use System where ADE occurred
" Preventable ADE impact on the patient
" Intervention necessary due to the preventable ADE
The data gathered via the mandatory reporting system would not only be used to determine
compliance but an additional educational component would be included. Information from the
system would be used to create a best practices online decision support system accessible by all
hospitals.
6.1.2 Network Design
The diagram below illustrates the flow of information between a hospital and the mandatory
reporting system.
44
Network Diagram for Mandatory Reporting
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Figure 5 - Network Diagram Mandatory Reporting
The hospital would transmit the necessary data over in the internet where it would be compiled
by an agency of the Federal Government (1). Once the data has been received and stored, a copy
of the data will be created with all patient level detail removed so that each patient remain
anonymous (2). The cleaned data would then be made available to the public via the internet (3).
Each hospital in the country could be queried as to the number of preventable ADE's, how often
they occurred and how severe the consequences were due to the error.
6.2 Incentive Structure
It is foolish to expect the health care industry to address preventable ADE's when their incentive
structures are not impacted by the quality of care being provided. Simply put, hospitals are paid
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based on the volume of services they render versus the level of care received by their patients.
One way to incent hospitals to address preventable ADE reduction is to incorporate tiered based
reimbursement systems where hospitals receive a larger portion of Medicare and Medicaid costs
based upon the incident rates of preventable ADE's within their hospital.
The recommendation is to create a reimbursement system which takes into account
incident rates for preventable ADE's. Hospitals receive a significant portion of their yearly
revenue from the government for all Medicare and Medicaid patients. The recommended system
would reimburse hospitals a greater portion of their claim depending upon their preventable
ADE incident rate. An example would be a hospital that had an incident rate of 1% would
receive 98 cents on every dollar. In comparison a hospital with a 3% incident rate would receive
85 cents on every dollar. A tiered based reimbursement system will help incent hospitals to
improve the level of care that they are providing.
6.3 Process Improvement
As previously stated, the use of technology to reduce errors without addressing the underlying
process will only achieve limited results. One common methodology used in process
improvement is known as DMAIC or define, measure, analyze, improve and control. The
methodology can be defined as follows;
" Define the process improvement goals that are consistent with customer demands and
enterprise strategy.
" Measure the current process and collect relevant data for future comparison.
" Analyze to verify relationship and causality of factors. Determine what the relationship
is, and attempt to ensure that all factors have been considered.
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" Improve or optimize the process based upon the analysis using techniques like Design of
Experiments.
" Control to ensure that any variances are corrected before they result in defects. Set up
pilot runs to establish process capability, transition to production and thereafter
continuously measure the process and institute control mechanisms.
A hospital in Illinois recently focused on using process improvement as the major means
for reducing medication administering errors. Using the DMAIC methodology, the hospital was
able to reduce their medication order entry errors to 0.04 per bed (Benitez et al., 2007). Tools
such as VOC (Voice Of Customer) and QFD (Quality Function Deploymcnt) provided the team
with a systematic way of identifying tasks within a process that needed to be streamlined and
improved.
The VOC is a process in which a "customers" needs are identified and organized into a
structure which allows for the requirements to be prioritized (Appendix E). The customer helps
determine the importance of each need in relation to other needs and the overall desired outcome.
Involving those that are the most impacted by the process creates joint ownership and helps
improve the chances the new solution will be successfully adopted. The QFD matrix is used to
take the customer's needs from the VOC and transform them into actionable and prioritized
goals. In the case of the hospital, the QFD was used to create the design requirements for the
new processes that were being implemented.
Using the DMAIC ,methodology assures that a team not only assesses how computerized
technology might improve a process but how the process itself can reengineered to provide better
results.
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6.4 Decision Support Systems
Using the Nebeker study, the prescribing, administering and monitoring stages of the Medication
Use System harbored the majority of the errors responsible for the preventable ADE's. All of
these three stages rely heavily on a clinician's knowledge and experience rather than the
automation or streamlining of tasks. This is clearly detailed in the results shown in Figure 3
where the hospital studied had extensive computer system integration but lacked decision
support functionality with drug dosage, selection and monitoring capability.
Examples of decision support systems include solutions such as infusion smart pumps
and databases which provide best practice information. However, like any program, decision
support systems are only effective when used. Literature has shown that many systems are not
utilized due to a false perception of risk, difficulty in using the system itself, and failures to
update necessary drug library databases when errors are identified (ISMP, 2007). The main
objective of all decision support systems is to reduce patient care variability and provide
clinicians with the most up to date information. While many people may believe that these types
of systems do not allow for the individualized thinking and action that is so highly coveted
within the health care industry, the main objective should be to reduce the variances in care
received between the best and worst clinician.
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7 Future Research
Mandatory reporting of all preventable ADE's carries the greatest opportunity for disrupting the
health care industry. Several industry agencies have expressed that the mandatory reporting of
errors would only serve to reduce the quality of care provided to the public. In addition, it has
been expressed that providing error data to the public is a poor way of communicating the level
of care that can be expected at a particular facility. However, there is a lack of quantitative data
that supports many of these statements.
In response to a California law that was recently passed which will mandate the reporting
of all Adverse Drug Events; Kasey Thompson, director of patient safety for AHSP comments
"When a medication error results in death or injury, it is very difficult for a facility to sweep it
under the rug. But using medication errors to compare facilities is problematic. And to use the
information to publicly embarrass hospitals could have a chilling effect on reporting and the
creation of the kind of database of errors that could improve safety." (Sipkoff, 2006).
It would be beneficial to study states where mandatory reporting programs currently exist
in an effort to determine the impact on reporting frequency. In addition, the relationship between
the repercussions of failing to report a preventable ADE and observed reporting rate should be
examined. This information would help determine the necessary punitive system required to
obtain the level of reporting to improve the public health care system.
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The majority of the recommended solutions would have substantial costs attached to their
implementation. For example, a highly integrated computerized system with decision support
capability can run approximately $5 million for community sized hospitals and in excess of $20
million for very large medical centers (USA Today, 2006).
It would be beneficial to understand the financial impact these solutions would have on a
hospitals ability to continue to provide patient care and the incremental costs that would be
passed on to the consumer. The U.S. hospital system is run by public companies that are in
business to make reasonable returns on their investments. If the costs of systems to reduce errors
make the business environment unprofitable, you could see an already strained health care
system become even weaker. In any case, the costs of these systems need to be balanced with an
acceptable level of risk that the public is willing to accept.
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Appendix A - Online Public Survey
Survey Methodology
The following survey was sent via email to approximately 300 people. Of the approximately 300 people who
received the survey, 173 answered all five questions.
Question 1
In a hospital, how many medication errors per day do you think a single patient is subject to?
Respondents
125
35
8
0
5
0
173
Percentage
72.25%
20.23%
4.62%
0.00%
2.89%
0.00%
100.00%
Question 2
In a hospital, specific to your care, how many medication errors per day would you accept
before seeking another hospital to obtain health care services from?
Respondents
71
94
8
0
0
0
173
Percentage
41.04%
54.34%
4.62%
0.00%
0.00%
0.00%
100.00%
54
Errors
0
1
2
3
4
5
Errors
0
1
2
3
4
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Question 3
How many times were you aware that there was an error made in the type or dose of
medication given to you?
Respondents
130
25
9
9
173
Percentage
75.14%
14.45%
5.20%
5.20%
0.00%
0.00%
100.00%
Question 4
Have you ever inquired about your doctor or hospitals level of care being offered?
Respondents
103
70
173
Percentage
59.54%
40.46%
100.00%
Question 5
What types of medication errors do you think should be reported to the public by a hospital?
(U.S. News Ranking Reports, Board Certifications, Medical School)
Respondents
Preventable Death
Causing Permanent Impairment
Any Error Requiring Additional Treatment
Any Medication Error
145
143
112
73
Percentage
83.82%
82.66%
64.74%
42.20%
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Appendix B - Pyxis MedStation
Pyxis MedStation automates the distribution, tracking,
management and security of medications and drives
improvements in quality and efficiency.
Proven to reduce chances of medication errors, Pyxis
MedStation supports safe, efficient medication dispensing in
patient care areas.
Saves nursing and pharmacy time, providing more time for
clinical patient care
" Helps increase patient safety
" Supports timely administration of medication
" Controls which medications users can access
* Supports JCAHO and regulatory compliance
* Increases charge and cost capture
MedStation consists of a touch screen computer attached to a
number of modules for drug storage in specially designed,
compartmentalized drawers. Users log in using the touch screen
and once authenticated, they can access patient profiles showing
the med list for each patient. Drawers are opened for med
removal by simply selecting the desired med on the med list.
Pyxis MedStation
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Appendix C - Alaris Pump
The Alaris pump is a modular point-of-care
infusion device that integrates infusion, patient
monitoring and clinical best practice guidelines in a
single platform for optimal outcomes. The modules
provide flexibility in managing to the unique needs
of the specific patient while maximizing asset
utilization.
It consists of a main control module (a.k.a. PC) and
up to four different modules plus a bar-code
scanner that can be connected to the main control
unit. Each pump is associated to a patient in a room
and can be automatically programmed by simply
scanning the medication.
V 
jr
Alaris Pump
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Appendix D- National Quality Forum Guidelines
SERIOUS REPORTABLE EVENTS
Surgical Events
- Intra-Operative or Immediately Postoperative Death in an ASA Class I Patient.
" Surgery Performed on the Wrong Body Part
- Surgery Performed on the Wrong Patient
- Wrong Surgical Procedure Performed on a Patient
- Unintended Retention of a Foreign Object in a Patient after Surgery or Other Procedure
Product or Device Events
- Patient Death or Serious Disability Associated with Intravascular Air Embolism that Occurs
while being Cared for in a Healthcare Facility
- Patient Death or Serious Disability Associated with the Use of Contaminated Drugs, Devices,
or Biologics Provided by the Healthcare Facility
- Patient Death or Serious Disability Associated with the Use or Function of a Device in Patient
Care in which the Device is Used or Functions Other Than as Intended
Patient Protection Events
- Infant Discharged to the Wrong Person
- Patient Death or Serious Disability Associated with Patient Elopement (Disappearance)
" Patient Suicide, or Attempted Suicide, Resulting in Serious Disability while being Cared for in
a Healthcare Facility
Care Management Events
- Artificial Insemination with the Wrong Donor Sperm or Wrong Egg
" Death or Serious Disability Associated with Failure to Identify and Treat Hyperbilirubinemia in
Neonates (Kernicterus)
- Maternal Death or Serious Disability Associated with Labor or Delivery in a Low-Risk
Pregnancy while being Cared for in a Healthcare Facility
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- Patient Death or Serious Disability Associated with a Hemolytic Reaction due to the
Administration of ABO/HLA-Incompatible Blood or Blood Products
- Patient Death or Serious Disability Associated with Hypoglycemia, the Onset of which Occurs
while the Patient is being Cared for in a Healthcare Facility
- Patient Death or Serious Disability Associated with a Medication Error (e.g., errors involving
the wrong drug, wrong dose, wrong patient, wrong time, wrong rate, wrong preparation, or
wrong route of administration)
- Patient Death or Serious Disability due to Spinal Manipulative Therapy
- Stage 3 or 4 Pressure Ulcers Acquired after Admission to a Healthcare Facility
Environmental Events
- Any Incident in which a Line Designated for Oxygen or Other Gas to be Delivered to a Patient
Contains the Wrong Gas or is Contaminated by Toxic Substances
- Patient Death or Serious Disability Associated with a Burn Incurred from Any Source while
being Cared for in a Healthcare Facility
- Patient Death or Serious Disability Associated with an Electric Shock while being Cared for in
a Healthcare Facility
- Patient Death or Serious Disability Associated with a Fall while being Cared for in a
Healthcare Facility
- Patient Death or Serious Disability Associated with the Use of Restraints or Bedrails while
being Cared for in a Healthcare Facility
Criminal Events
- Abduction of a Patient of Any Age
- Any Instance of Care Ordered by or Provided by Someone Impersonating a Physician, Nurse,
Pharmacist, or Other Licensed Healthcare Provider
- Death or Significant Injury of a Patient or Staff Member Resulting from a Physical Assault
(i.e., battery) that occurs within or on the Grounds of the Healthcare Facility
- Sexual Assault on a Patient within or on the Grounds of the Healthcare Facility
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Appendix E- VOC (Voice of Customer)
Nurses need
Quick access
Quick pharmacy
turnaround time
Defined as:
Available immediately for printing (less than one minuteL,
Less than three steps to access the document.
Less than two hours.
Fax of order available in real time.
j Hierarchy
2%
38%
7
Provide history Able to see all medications for the entire patient stay, 2
of meds Able to see medication start and stop dates. 2%
Portable/mobile Nurse should not need to go back to station for doC umenti{ 2%
Check on MAR
Trustworthy
Serve to double check all orders in medication
administration record (MAR)
Medications sort in the same way as MAR.
At least 95% accurate the first time.
Consistency in order entry by all pharmacists.
Source: Benitez, 2007
12%
19%
7%
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Appendix F- QFD (Quality Function Deployment)
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